Luttagen 21 Tab

What is Luttagen Luttagen is a female hormone important for the regulation of ovulation and menstruation. Luttagen is used to cause menstrual periods in women who have not yet reached menopause but are not having periods due to a lack of Luttagen in the body. Luttagen is also used to prevent overgrowth in the lining of the uterus in postmenopausal women who are receiving estrogen hormone replacement therapy. Luttagen should not be used to prevent heart disease or dementia, because Luttagen may actually increase your risk of developing these conditions. Luttagen may also be used for other purposes not listed in Luttagen guide. Luttagen side effects Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using Luttagen and call your doctor at once if you have any of these serious side effects: sudden numbness or weakness, especially on one side of the body; sudden headache, confusion, pain behind the eyes, problems with vision, speech, or balance; fast or pounding heartbeats; chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling; unusual or unexpected vaginal bleeding; migraine headache; nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice ; swelling in your hands, ankles, or feet; fever, chills, body aches, flu symptoms; a breast lump; or symptoms of depression (sleep problems, weakness, mood changes). Less serious side effects may include: mild nausea, diarrhea, bloating, stomach cramps; dizziness, spinning sensation; hot flashes; mild headache; joint pain; breast pain or tenderness; cough; acne or increased hair growth; changes in weight; or vaginal itching, dryness, or discharge. More: https://www.gmedication.com/?s=luttagen Luttagen dosing Usual Adult Dose for Amenorrhea: 5 to 10 mg IM for six to eight consecutive days. 400 mg orally for 10 days. Give dose in the evening. Secondary Amenorrhea: 90 mg intravaginally, 4% gel, every other day for a total of six doses. If no response observed, the administration of the 8% gel every other day for a total of six doses may be used. Usual Adult Dose for Uterine Bleeding: 5 to 10 mg IM daily for 6 doses. Usual Adult Dose for Endometrial Hyperplasia -- Prophylaxis: 200 mg orally for 12 consecutive days, per 28 day cycle. Give dose in the evening. Usual Adult Dose for Luttagen Insufficiency: Assisted Reproductive Technology - Gel: 90 mg of the 8% gel, once daily intravaginally, in women who require supplementation. 90 mg of the 8% gel, twice daily intravaginally, in women with partial or complete ovarian failure who require replacement. If pregnancy occurs, therapy with the intravaginal gel may be continued until placental autonomy is achieved, up to 10 to 12 weeks. Assisted Reproductive Technology (ART) - Vaginal Insert 100 mg administered vaginally two or three times daily starting at oocyte retrieval and continuing for up to 10 weeks total duration. Efficacy in women 35 years of age and older has not been clearly established. The appropriate dose in this age group has not been determined. Luttagen deficiency associated with menopause and perimenopause: Luttagen 1.7% topical cream: rub 1/4 to 1/2 teaspoon into the palms of the hands, soles of the feet, or other soft areas of skin once or twice daily. Usual Adult Dose for Premature Labor: Study (n=459) - National Institute of Child Health and Human Development (NICHD) - Prevention of Recurrent Preterm Delivery in Women at High Risk: 17-alpha-hydroxyprogesterone caproate (17P) 250 mg IM once weekly starting on the 21st week of gestation through time of delivery or week 36 of gestation. Study (n=142) - Reduce Incidence of Spontaneous Preterm Birth in Women at Increased Risk: 100 mg vaginal suppository daily, between 24 and 34 weeks of gestation. Usual Adult Dose for Seizures: - Catamenial epilepsy [complex partial or secondary generalized motor seizures]: 200 mg lozenge three times daily administered in relation to pattern of seizure exacerbation during luteal phase of menstrual cycle. For patients with perimenstrual exacerbation, dose was provided on day 23 through day 25 of menstrual cycle. For patients with seizure exacerbation during entire luteal phase, dose was provided on day 15 through day 25 of each menstrual cycle. The desired Luttagen serum level was between 5 and 25 ng/mL 4 hours after taking the lozenge. All patients continued taking their best antiseizure medication. Usual Adult Dose for Perimenopausal Symptoms: Luttagen deficiency associated with menopause and perimenopause: Luttagen 1.7% topical cream: Rub 1/4 to 1/2 teaspoonful into the palms of the hands, soles of feet, or other soft area once or twice daily. Active ingredients: Progesterone More: https://www.gmedication.com/?s=luttagen